Sutro Biopharma (STRO) Amortizatization of Intangibles (2017 - 2025)

Sutro Biopharma has reported Amortizatization of Intangibles for 9 years, with the latest figure at $531000.0 in Q4 2025.

• Quarterly Amortizatization of Intangibles fell 65.5% year-over-year to $531000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.4 million (down 64.66% YoY) and the FY2025 annual result came in at $3.4 million, down 64.66% from the prior year.
• Amortizatization of Intangibles eased to $531000.0 in Q4 2025 per STRO's latest filing, from $755000.0 in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $3.1 million in Q4 2023 and troughed at -$799000.0 in Q4 2021.
• A 5-year average of $990600.0 and a median of $1.1 million in 2025 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2021 and 2023: Amortizatization of Intangibles plunged 1309.76% in 2021, then surged 2224.27% in 2023.
• Over 5 years, Amortizatization of Intangibles stood at -$799000.0 in 2021, then surged by 246.93% to $1.2 million in 2022, then surged by 160.05% to $3.1 million in 2023, then plunged by 49.59% to $1.5 million in 2024, then sank by 65.5% to $531000.0 in 2025.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $531000.0, $755000.0, and $1.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.